Status: Recruiting
Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial
The clinical investigation is a non-randomized, multicenter, open-label, prospective, exposure-time escalation clinical investigation. The clinical investigation is designed to assess the clinical safety and performance of the Oncomagnetic Device.
Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: BioTex, Inc.Updated: Jun 2, 2026Locations: 6
Eligibility criteria
The subject is at least 18 years of age. [+9]
The subject has a tumor in the brainstem, extensive or multicentric disease (e.g... [+12]